Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling

SIMPLE SUMMARY: Drug resistance is a long-standing impediment to effective systemic cancer therapy and acquired drug resistance is a growing problem for new therapeutics that otherwise have shown significant successes in disease control. Hepatocyte growth factor (HGF)/Met receptor pathway signaling...

Descripción completa

Detalles Bibliográficos
Autores principales: Cecchi, Fabiola, Rex, Karen, Schmidt, Joanna, Vocke, Cathy D., Lee, Young H., Burkett, Sandra, Baker, Daniel, Damore, Michael A., Coxon, Angela, Burgess, Teresa L., Bottaro, Donald P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857108/
https://www.ncbi.nlm.nih.gov/pubmed/36672409
http://dx.doi.org/10.3390/cancers15020460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857108/
https://www.ncbi.nlm.nih.gov/pubmed/36672409
http://dx.doi.org/10.3390/cancers15020460

Ejemplares similares